Shenzhen, China

Guanhao Ye

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Shenzhen Salubris Pharmaceuticals Co. Ltd.. Active years: 2017.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guanhao Ye: Innovator in Pharmaceutical Composition

Introduction

Guanhao Ye is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the stability and production efficiency of pharmaceutical compounds.

Latest Patents

Guanhao Ye holds a patent for "Amorphous allisartan isoproxil, preparation method therefor, and pharmaceutical composition containing amorphous allisartan isoproxil." This invention relates to an amorphous form of allisartan isoproxil, an angiotensin II receptor blocker. The amorphous allisartan isoproxil exhibits excellent flowability and a large bulk density, minimizing electrostatic phenomena. This innovation effectively reduces dust pollution during production, thereby facilitating the manufacturing process of allisartan isoproxil. The pharmaceutical composition derived from this invention is highly stable, ensuring the quality of the drug formulation.

Career Highlights

Guanhao Ye is associated with Shenzhen Salubris Pharmaceuticals Co. Ltd., where he continues to advance his research and development efforts. His work has been instrumental in improving pharmaceutical formulations, contributing to better drug delivery systems.

Collaborations

Guanhao Ye collaborates with esteemed colleagues, including Duanming Tan and Jun Ou. Their combined expertise fosters a productive research environment, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Guanhao Ye's contributions to pharmaceutical innovation, particularly through his patent on amorphous allisartan isoproxil, highlight his role as a key inventor in the field. His work not only enhances drug stability but also improves production efficiency, making a significant impact on pharmaceutical manufacturing.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…